Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;94(7):2659-64.
doi: 10.1016/j.fertnstert.2010.03.077. Epub 2010 May 7.

Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents

Emily S Jungheim  1 , Anthony O Odibo
Affiliations
Review

Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents

Emily S Jungheim et al. Fertil Steril. 2010 Dec.

Abstract

Objective: To compare different oral ovulation induction agents in treating infertile women with polycystic ovary syndrome (PCOS).

Design: Decision-analytic model comparing three treatment strategies using probability estimates derived from literature review and sensitivity analyses performed on the baseline assumptions.

Setting: Outpatient reproductive medicine and gynecology practices.

Patient(s): Infertile women with PCOS.

Intervention(s): Metformin, clomiphene citrate, or metformin with clomiphene citrate.

Main outcome measure(s): Live birth.

Result(s): Within the baseline assumptions, combination therapy with metformin and clomiphene citrate was the preferred therapy for achieving live birth in women with PCOS. Sensitivity analysis revealed the model to be robust over a wide range of probabilities.

Conclusion(s): Combination therapy with metformin and clomiphene citrate should be considered as first-line treatment for infertile women with PCOS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Decision model for oral ovulation induction agents for fertility treatment in women with polycystic ovary syndrome.
Fig. 2
Fig. 2
Tornado diagram summary of the 1-way sensitivity analysis for ovulation induction in women with polycystic ovary syndrome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113–6. - PubMed
    1. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:524–30. - PubMed
    1. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551–66. - PubMed
    1. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006;332:1485. - PMC - PubMed
    1. Zain MM, Jamaluddin R, Ibrahim A, Norman RJ. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2009;91:514–21. - PubMed

MeSH terms